Wang et al. (25) reported that inhibition of the m6A methylation by depletion of METTL3 and METTL14, enhanced response to anti-programmed cell death-1 (PD-1) treatments in colorectal cancer and melanoma. The gene discussed is PDCD1; the disease is melanoma.